Sonora Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $43K | Buy |
560
+100
| +22% | +$7.68K | 0.01% | 443 |
|
|
2021
Q2 | $38K | Hold |
460
| – | – | 0.01% | 447 |
|
|
2021
Q1 | $35K | Hold |
460
| – | – | ﹤0.01% | 716 |
|
|
2020
Q4 | $40K | Hold |
460
| – | – | ﹤0.01% | 686 |
|
|
2020
Q3 | $35K | Sell |
460
-490
| -52% | -$37.3K | ﹤0.01% | 684 |
|
|
2020
Q2 | $117K | Buy |
950
+450
| +90% | +$55.4K | 0.01% | 308 |
|
|
2020
Q1 | $42K | Hold |
500
| – | – | 0.01% | 540 |
|
|
2019
Q4 | $42K | Sell |
500
-28
| -5% | -$2.35K | ﹤0.01% | 612 |
|
|
2019
Q3 | $36K | Sell |
528
-172
| -25% | -$11.7K | ﹤0.01% | 626 |
|
|
2019
Q2 | $60K | Hold |
700
| – | – | 0.01% | 451 |
|
|
2019
Q1 | $62K | Buy |
700
+200
| +40% | +$17.7K | 0.01% | 414 |
|
|
2018
Q4 | $43K | Hold |
500
| – | – | 0.01% | 431 |
|
|
2018
Q3 | $48K | Sell |
500
-100
| -17% | -$9.6K | 0.01% | 425 |
|
|
2018
Q2 | $57K | Hold |
600
| – | – | 0.01% | 360 |
|
|
2018
Q1 | $48.6K | Hold |
600
| – | – | 0.01% | 403 |
|
|
2017
Q4 | $53.5K | Hold |
600
| – | – | 0.01% | 386 |
|
|
2017
Q3 | $55.8K | Hold |
600
| – | – | 0.01% | 329 |
|
|
2017
Q2 | $54.5K | Hold |
600
| – | – | 0.01% | 322 |
|
|
2017
Q1 | $52.7K | Hold |
600
| – | – | 0.01% | 328 |
|
|
2016
Q4 | $49.7K | Sell |
600
-50
| -8% | -$4.14K | 0.01% | 296 |
|
|
2016
Q3 | $60.1K | Hold |
650
| – | – | 0.01% | 273 |
|
|
2016
Q2 | $50.6K | Sell |
650
-25
| -4% | -$1.95K | 0.01% | 268 |
|
|
2016
Q1 | $60.9K | Hold |
675
| – | – | 0.01% | 260 |
|
|
2015
Q4 | $71K | Hold |
675
| – | – | 0.02% | 189 |
|
|
2015
Q3 | $85K | Buy |
+675
| New | +$85K | 0.03% | 161 |
|